InChIKey	FIKPXCOQUIZNHB-WDEREUQCSA-N
Compound Name	Repotrectinib
Canonical SMILES	C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	9
Pfam Stratification	Cross-Family
Avg pChEMBL	8.92
Source	ChEMBL;BindingDB

DrugBank ID	DB16826
Drug Name	Repotrectinib
CAS Number	1802220-02-5
Groups	approved investigational
ATC Codes	L01EX28
Description	Repotrectinib is a next-generation tyrosine kinase inhibitor (TKI) specifically designed to address resistance in the treatment of non-small cell lung cancer (NSCLC), specifically due to mutations in the ROS1 gene.[A262056] ROS1 mutations are one of the defined oncogenic drives of NSCLC, and the sol...

---

Categories: Antineoplastic Agents Antineoplastic and Immunomodulating Agents BCRP/ABCG2 Inhibitors Cytochrome P-450 CYP2B6 Inducers Cytochrome P-450 CYP2B6 Inducers (strength unknown) Cytochrome P-450 CYP2C19 Inducers Cytochrome P-450 CYP2C19 Inducers (strength unknown) Cytochrome P-450 CYP2C8 Inducers Cytochrome P-450 CYP2C8 Inducers (strength unknown) Cytochrome P-450 CYP2C9 Inducers Cytochrome P-450 CYP2C9 Inducers (strength unknown) Cytochrome P-450 CYP3A Inducers Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inducers Cytochrome P-450 CYP3A4 Inducers (strength unknown) Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Inhibitors Cytochrome P-450 CYP3A5 Inhibitors (strength unknown) Cytochrome P-450 Enzyme Inducers Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Kinase Inhibitor MATE 2 Inhibitors MATE inhibitors OATP1B1/SLCO1B1 Inhibitors P-glycoprotein inhibitors P-glycoprotein substrates Protein Kinase Inhibitors ROS1 tyrosine kinase inhibitors Tyrosine Kinase Inhibitors UGT1A1 Inhibitors

---

Cross-references: BindingDB: 374727 CHEMBL4298138 ChemSpider: 64853849 Drugs Product Database (DPD): 27017 PDB: 7GI RxCUI: 2670644 Wikipedia: Repotrectinib